AbbVie
A Senior Scientist at AbbVie leads scientific initiatives in the development of targeted Lipid Nanoparticle (tLNP) assets, focusing on formulation and process development, stability evaluations, and clinical in-use strategies. The role involves collaboration across multiple teams to advance drug product development from early-stage research to commercialization.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
AbbVie didn’t post a salary, so this is our estimate from similar listings.
Senior Scientist I, tLNP Formulation
AbbVie
Scientist II / Senior Scientist, I, tLNP Process Development
AbbVie
Senior Associate Scientist, LNP Formulation
Kernal Biologics, Inc.
Senior Research Associate – Targeted LNP Formulation (Non-Viral Delivery)
Bristol Myers Squibb
Scientist I, Nanoparticle Formulation and Process Development
BreezeBio
Research Associate, Formulation Development
Pivotal